DE60217139D1 - Kombination von einem pde-hemmer und eines leukotrien rezeptor antagonisten - Google Patents

Kombination von einem pde-hemmer und eines leukotrien rezeptor antagonisten

Info

Publication number
DE60217139D1
DE60217139D1 DE60217139T DE60217139T DE60217139D1 DE 60217139 D1 DE60217139 D1 DE 60217139D1 DE 60217139 T DE60217139 T DE 60217139T DE 60217139 T DE60217139 T DE 60217139T DE 60217139 D1 DE60217139 D1 DE 60217139D1
Authority
DE
Germany
Prior art keywords
leukotria
combination
receptor antagonist
pde inhibitor
pde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60217139T
Other languages
English (en)
Other versions
DE60217139T2 (de
Inventor
Rolf Beume
Christian Weimar
Stefan-Lutz Wollin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Application granted granted Critical
Publication of DE60217139D1 publication Critical patent/DE60217139D1/de
Publication of DE60217139T2 publication Critical patent/DE60217139T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60217139T 2001-09-19 2002-09-17 Kombination von einem pde-hemmer und eines leukotrien rezeptor antagonisten Expired - Lifetime DE60217139T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01000474 2001-09-19
EP01000474 2001-09-19
PCT/EP2002/010423 WO2003024488A2 (en) 2001-09-19 2002-09-17 Combination of a pde inhibitor and a leukotriene receptor antagonist

Publications (2)

Publication Number Publication Date
DE60217139D1 true DE60217139D1 (de) 2007-02-08
DE60217139T2 DE60217139T2 (de) 2007-10-04

Family

ID=8176066

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60217139T Expired - Lifetime DE60217139T2 (de) 2001-09-19 2002-09-17 Kombination von einem pde-hemmer und eines leukotrien rezeptor antagonisten

Country Status (26)

Country Link
US (1) US20050014762A1 (de)
EP (1) EP1429843B1 (de)
JP (1) JP2005505570A (de)
KR (1) KR20040044946A (de)
CN (1) CN100346831C (de)
AT (1) ATE349243T1 (de)
BR (1) BR0212582A (de)
CA (1) CA2460442A1 (de)
CO (1) CO5560584A2 (de)
CY (1) CY1106365T1 (de)
DE (1) DE60217139T2 (de)
DK (1) DK1429843T3 (de)
EA (1) EA007736B1 (de)
ES (1) ES2279004T3 (de)
HK (1) HK1066752A1 (de)
HU (1) HUP0500078A3 (de)
IL (2) IL160272A0 (de)
MA (1) MA27136A1 (de)
MX (1) MXPA04002560A (de)
NO (1) NO331885B1 (de)
NZ (1) NZ532279A (de)
PL (1) PL205927B1 (de)
PT (1) PT1429843E (de)
SI (1) SI1429843T1 (de)
WO (1) WO2003024488A2 (de)
ZA (1) ZA200402653B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719518D0 (en) * 2007-10-05 2007-11-14 Therapeutics Ltd E Therapy
WO2009052624A1 (en) * 2007-10-25 2009-04-30 Merck Frosst Canada Ltd. Combination therapy
WO2012168907A1 (en) 2011-06-10 2012-12-13 Glenmark Pharmaceuticals Sa Pharmaceutical composition comprising revamilast and montelukast or zafirlukast
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
PE20151332A1 (es) 2013-02-19 2015-09-20 Pfizer Compuestos de azabencimidazol
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US20160339010A1 (en) 2014-01-22 2016-11-24 Takeda Gmbh Treatment of Partly Controlled or Uncontrolled Severe Asthma
JP6713982B2 (ja) 2014-07-24 2020-06-24 ファイザー・インク ピラゾロピリミジン化合物
DK3177624T3 (da) 2014-08-06 2019-07-01 Pfizer Imidazopyridazinforbindelser

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028986A1 (es) * 1999-02-23 2003-06-04 Smithkline Beecham Corp USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA
EA006685B1 (ru) * 1999-08-21 2006-02-24 Алтана Фарма Аг Синергетическая композиция
MY134008A (en) * 1999-12-22 2007-11-30 Merck Frosst Canada Inc Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors
MXPA02007419A (es) * 2000-01-31 2002-12-09 Pfizer Prod Inc Derivados de nicotinamida benzocondensada-heterociclilo utiles como inhibidores selectivos de las isozimas pde4.
MY123585A (en) * 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
AU6196201A (en) * 2000-05-25 2001-12-03 Merck Frosst Canada Inc Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor

Also Published As

Publication number Publication date
HK1066752A1 (en) 2005-04-01
WO2003024488A2 (en) 2003-03-27
US20050014762A1 (en) 2005-01-20
PL367414A1 (en) 2005-02-21
WO2003024488A3 (en) 2003-09-04
NO331885B1 (no) 2012-04-30
DE60217139T2 (de) 2007-10-04
EP1429843A2 (de) 2004-06-23
KR20040044946A (ko) 2004-05-31
CO5560584A2 (es) 2005-09-30
PT1429843E (pt) 2007-03-30
CA2460442A1 (en) 2003-03-27
BR0212582A (pt) 2004-10-13
SI1429843T1 (sl) 2007-06-30
CY1106365T1 (el) 2011-10-12
HUP0500078A2 (hu) 2005-04-28
EP1429843B1 (de) 2006-12-27
ES2279004T3 (es) 2007-08-16
EA007736B1 (ru) 2006-12-29
EA200400416A1 (ru) 2004-12-30
MA27136A1 (fr) 2005-01-03
NZ532279A (en) 2006-02-24
ZA200402653B (en) 2005-02-14
ATE349243T1 (de) 2007-01-15
CN100346831C (zh) 2007-11-07
NO20041595L (no) 2004-06-16
HUP0500078A3 (en) 2010-07-28
MXPA04002560A (es) 2004-05-31
JP2005505570A (ja) 2005-02-24
PL205927B1 (pl) 2010-06-30
IL160272A0 (en) 2004-07-25
IL160272A (en) 2008-03-20
CN1655846A (zh) 2005-08-17
DK1429843T3 (da) 2007-04-30

Similar Documents

Publication Publication Date Title
CY1106927T1 (el) Φαρμακευτικη συνθεση ενος pde4 ή pde3/4 αναστολεα και ανταγωνιστη υποδοχεα ισταμινης
CY1106365T1 (el) Συνδυασμος ενος αναστολεα pde και ενος ανταγωνιστη υποδοχεων λευκοτριενιου
WO2005072308A3 (en) Cgrp receptor antagonists
DE60214198D1 (de) Isoxazolyl-pyrimidines als inhibitoren von src- und lck-protein-kinasen
ATE557026T1 (de) Vasopressin v1a antagonisten
DE60324788D1 (de) Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit
DE602005027230D1 (de) Cgrp-rezeptorantagonisten
ATE348101T1 (de) Carbolin derivate als hemmstoffe von phospphodiesterase 5 (pde5) zur behandlung kardiovaskulärer erkrankungen und der erektilen dysfunktion
WO2002081728A3 (en) Quinoline inhibitors of hyak1 and hyak3 kinases
ATE371454T1 (de) Antagonisten der prostaglandin ep2 und/oder ep4 rezeptoren zur behandlung von menorrhagie
ID29818A (id) Penggunaan antagonis reseptor angiotensin ii untuk mengobati infarksi miokardial
RS56006B1 (sr) Korišćenje inhibitora il-18 za lečenje ili prevenciju povreda cns
NO20026085D0 (no) Ny anvendelse av angiotensin II antagonister
HUP0401858A3 (en) Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
NO20033634L (no) GLyT-1-inhibitorer
HUP0303754A3 (en) Use of radical scavenging compounds for preparation of pharmaceutical compsoition suitable for treatment and prevention of no-dependent microcirculation disorders
BRPI0419110A (pt) antagonistas de bifenil integrina

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: BEUME, ROLF, 78465 KONSTANZ, DE

Inventor name: WEIMAR, CHRISTIAN, 78467 KONSTANZ, DE

Inventor name: WOLLIN, STEFAN-LUTZ, 88709 MEERSBURG, DE

Inventor name: BUNDSCHUH, DANIELA, ERMATINGEN, CH

8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE

8364 No opposition during term of opposition